Literature DB >> 11693333

Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.

T M Bauer1, B Steinbrückner, F E Brinkmann, A K Ditzen, H Schwacha, J J Aponte, K Pelz, M Kist, H E Blum.   

Abstract

OBJECTIVES: The significance of small intestinal bacterial overgrowth in patients with cirrhosis is not fully understood and its diagnostic criteria are not uniform. We examined the association of small intestinal bacterial overgrowth with spontaneous bacterial peritonitis and compared various microbiological criteria.
METHODS: Jejunal secretions from 70 patients with cirrhosis were cultivated quantitatively and classified according to various definitions. Clinical characteristics of patients were evaluated and the incidence of spontaneous bacterial peritonitis was monitored during a 1-yr follow-up.
RESULTS: Small intestinal bacterial overgrowth, defined as > or = 10(5) total colony-forming units/ml jejunal secretions, was present in 61% of patients. Small intestinal bacterial overgrowth was associated with acid-suppressive therapy (p = 0.01) and hypochlorhydria (p < 0.001). Twenty-nine patients with persistent ascites were observed. Six episodes of spontaneous bacterial peritonitis occurred after an average 12.8 wk. Occurence of spontaneous bacterial peritonitis correlated with ascitic fluid protein concentration (p = 0.01) and serum bilirubin (p = 0.04) but not with small intestinal bacterial overgrowth (p = 0.39). Its association with acid-suppressive therapy was of borderline significance (hazard ratio = 7.0, p = 0.08).
CONCLUSIONS: Small intestinal bacterial overgrowth in cirrhotic patients is associated with acid-suppressive therapy and hypochlorhydria, but not with spontaneous bacterial peritonitis. The potential role of acid-suppressive therapy in the pathogenesis of spontaneous bacterial peritonitis merits further studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11693333     DOI: 10.1111/j.1572-0241.2001.04668.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  78 in total

1.  Small Bowel Bacterial Overgrowth: Presentation, Diagnosis, and Treatment.

Authors:  Virmeet V. Singh; Phillip P. Toskes
Journal:  Curr Treat Options Gastroenterol       Date:  2004-02

2.  Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis.

Authors:  Daniel M Musher; Aran Cunningham Nichol; Adriana M Rueda
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Clostridium perfringens spontaneous bacterial peritonitis: report of a case and implications for management.

Authors:  Patrick E Young; Richard R Dobhan; Theodore W Schafer
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

Review 4.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

5.  Immunology and the evaluation of risk factors for development of spontaneous bacterial peritonitis.

Authors:  Charles J Diskin
Journal:  Dig Dis Sci       Date:  2007-10-17       Impact factor: 3.199

6.  How bile acids confer gut mucosal protection against bacteria.

Authors:  Alan F Hofmann; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

7.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27

Review 8.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations.

Authors:  Carmen C Franz; Carole Hildbrand; Christa Born; Sabin Egger; Alexandra E Rätz Bravo; Stephan Krähenbühl
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

10.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Hepatol Int       Date:  2018-10-04       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.